NFKB1 and hepatocellular carcinoma: Inhibition of NF-κB consistently suppresses P-gp expression and restores chemosensitivity, as shown in hepatocellular carcinoma where metformin or NF-κB siRNA downregulate MDR1 and resensitize resistant cells [199].